This article summarizes metabolic reprogramming in prostate cancer (PCa). Early PCa relies more on glycolysis.

SGLT2 inhibitors linked to lower hormone therapy failure in prostate cancer. Learn more about their potential role in improving treatment outcomes.

Study shows boosting diet with supplements could halt prostate tumour growth and help men avoid unnecessary surgery, chemo or radiotherapy ...

Prostate cancer is the second-most common cancer in men. A new study from Thomas Jefferson University uncovered a new ...

Add Yahoo as a preferred source to see more of our stories on Google. For men facing the return of prostate cancer, a new combination therapy may offer a much longer break before the disease comes ...

The addition of a Lactobacillus probiotic supplement to the phytochemical-rich food supplement significantly improved rate of PSA progression from 23.2% to -21.4% (44.6% change, P 0.001), compared to ...

Add Yahoo as a preferred source to see more of our stories on Google. Researchers found that specially designed supplements of vegetables and probiotics appeared to slow progression of an indicator of ...

Investigators compared clinical outcomes with docetaxel rechallenge vs cabazitaxel in patients with mCRPC who did not experience disease progression during prior administration of docetaxel for mCRPC.

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...